Nexalogy Working On AI Driven Mental Health Detection Tool

Toronto, Ontario–(Newsfile Corp. – October 27, 2022) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that its wholly-owned subsidiary, Nexalogy Environics Inc. (“Nexalogy“), is in the process of developing an artificial intelligence (“AI“) and machine learning (“ML“) tool to detect depression and anxiety. The tool explores sets of data and text to analyze and distinguish emotions and moods to determine one’s mental state and if the creator of that text is suffering specifically from depression or anxiety.

Nexalogy designed their tool to focus on depression and anxiety detection. The latest research suggests that the most prevalent mental illnesses are depression and anxiety which are estimated to affect nearly one in ten people worldwide, over 676 million people. Identifying these conditions in their early stages is critical in addressing the significant public health concerns surrounding these illnesses that lead to self-harm and suicide. (Source: https://arxiv.org/abs/2011.05249).

The Company believes this will be a beneficial tool in various industries such as the airline industry with pilots, soldiers in the military and doctors and nurses in the health care industry.

The outcomes thus far verified by the Nexalogy team demonstrate that the AI tool shows a high confidence level when detecting mental illness, circa 72% when detecting emotions through text.

The below diagram displays how the Nexalogy detection tool operates:

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/142112